Floyd E. Taub, M.D.


Phone: (303) 249-9174
Fax: (206) 984-4277
E-mail: ft@findcure.org

Floyd E. Taub, M.D., has spent 30 years studying pathology, immunology, oncology and infectious diseases. He has literally changed the paradigm in several fields:

  • Dr. Taub invented and implemented the first Computerized Image Processing Techniques to measure Gene Expression Levels (Genomics) via Arrays. He did this while at the National Institutes of Health (NCI) in 1999, significantly before the word “Genomics” existed.
  • Dr. Taub modernized PAP screening, the most important cancer screening test in existence. He started, and for 8 years led, the company (DIGENE) that developed the only FDA approved test to determine if a woman has, or is at high risk of developing, cervical cancer. Instead of using subjective morphologic criteria he instituted DNA determination of the presence of oncogenes in the high risk HPV types. This test was first approved for difficult cases and it is now approved a part of routine screening in the U.S.A. Scientific journals have suggested that in areas of the world with limited resources it should be the only screen used. It has been covered extensively by the lay press. In addition to detecting otherwise missed potentially lethal conditions, the test prevents unnecessary surgery in women who do not have a dangerous virus. It has become the “Gold Standard” in protection against cervical cancer.
  • Dr. Taub coined the terms NanoDrugs™ and Adaptive MicroMeds™ has led their development. This includes Phase I/II Clinical Trials, Clinical Outcome Studies and introduction of what is believed to be the most potent and among the safest scientifically documented drugs on the market. By modulating the immune system, Taurox™ and Beta LT ™ effectively reduce fatigue and often other symptoms in patients with neoplastic, infectious and post infectious syndromes including chronic viral hepatitis, Lyme Disease, cold & flu and cancer. Modulation of the expression of genes and cytokines has been documented in vitro and in vivo.
  • He started a non-profit called FindCure.Org (previously Victory Over Cancer and Chronic Conditions.) FindCure has dramatically accelerated the availability these drugs. He designed and participated in the performance and analysis of clinical trials.
  • Dr. Taub has developed drugs, which unlike standard cancer and hepatitis drugs, appear to meet what is commonly called the “Hippocratic Oath”. No prescription medicines and few other over-the-counter (OTC) medicines “do no harm”.
  • For the latest scientific finds on one of these drugs, Taurox™, see Dr. Taub's Presentation at Exeter University Medical School.

Breaking News:
CytoCore Names Digene Founder Dr. Floyd Taub as CEO